TriSalus Life Stock Forward View - Simple Regression
| TLSI Stock | 4.28 0.00 0.00% |
News-driven analysis for TriSalus Life seeks to separate meaningful signals from market noise. By filtering relevant headlines and sentiment trends, this module identifies potential catalysts that may move TriSalus Life's price.
At the latest evaluation, TriSalus Life posts the short-cycle RSI reading of 37, reflecting mild downside bias. Momentum below the midline but above oversold territory places TriSalus Life in a wait-and-see zone for many technical traders.Momentum
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter -0.09 | EPS Estimate Current Year -0.35 | EPS Estimate Next Year -0.20 | Wall Street Target Price 10.1 | EPS Estimate Current Quarter -0.13 |
The hype-based view summarizes TriSalus Life's price response to recent headlines and peer coverage.
The Simple Regression forecasted value of TriSalus Life Sciences on the next trading day is projected to be 4.00 with a mean absolute deviation of 0.36 and the sum of the absolute errors of 22.11.TriSalus Life after-hype prediction price | $ 4.08 |
This sentiment layer is designed to be read with forecasting, technical, analyst, earnings, and momentum context.
Historical Fundamental Analysis of TriSalus Life provides a cross-check on projections for TriSalus Life. The view provides historical context for the projection set.TriSalus Life Additional Predictive Modules
Most predictive techniques to examine TriSalus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for TriSalus using various technical indicators. When you analyze TriSalus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Simple Regression Price Forecast For the 17th of March 2026
Given 90 days horizon, the Simple Regression forecasted value of TriSalus Life Sciences on the next trading day is expected to be 4.00 with a mean absolute deviation of 0.36 , mean absolute percentage error of 0.17 , and the sum of the absolute errors of 22.11 .Please note that although there have been many attempts to predict TriSalus Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that TriSalus Life's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest TriSalus Life | TriSalus Life Price Prediction | Research Analysis |
Forecasted Value
This next-day forecast for TriSalus Life Sciences uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. At the moment, the model places downside around 0.04 and upside around 8.50 for the forecasting period.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of TriSalus Life stock data series using in forecasting. Note that when a statistical model is used to represent TriSalus Life stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.3336 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.3625 |
| MAPE | Mean absolute percentage error | 0.067 |
| SAE | Sum of the absolute errors | 22.115 |
Mean reversion in TriSalus Life is more reliable over longer time horizons. Short-term deviations can persist and even widen before correcting, making position sizing and risk management critical.
After-Hype Price Density Analysis
Investors who rely solely on expected value estimates for TriSalus Life miss the full picture. TriSalus Life's probability distribution reveals that expected value can be achieved through very different combinations of outcomes, each with different risk implications.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
The after-news price analysis for TriSalus Life is built on the observation that TriSalus Life's market reactions to news are not random but follow recognizable patterns. TriSalus Life's after-hype downside and upside margins for the prediction period are 0.20 and 8.56, respectively. Identifying and quantifying these patterns for TriSalus Life is the core purpose of this model.
Current Value
The next after-hype price estimate for TriSalus Life Sciences is modeled on a 3 months horizon and is intended to show how price could normalize after sentiment pressure fades. The objective is to separate event-driven enthusiasm from a more stable price path once the market absorbs the catalyst.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as TriSalus Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading TriSalus Life backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with TriSalus Life, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.88 | 4.50 | 0.05 | 0.16 | 9 Events | 7 Events | In 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
4.28 | 4.08 | 0.00 |
|
Hype Timeline
TriSalus Life Sciences is at this time traded for 4.28. The company has historical hype elasticity of 0.05, and average elasticity to hype of competition of -0.16. TriSalus is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at -0.88%. %. The volatility of related hype on TriSalus Life is about 2486.19%, with the expected price after the next announcement by competition of 4.12. About 35.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 2.12. TriSalus Life Sciences had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in 9 days. Historical Fundamental Analysis of TriSalus Life provides a cross-check on projections for TriSalus Life. The view provides historical context for the projection set.Related Hype Analysis
The information ratio and semi-deviation metrics in the peer comparison table for TriSalus Life provide a risk-adjusted view of how efficiently TriSalus Life's competitors convert news exposure into returns relative to downside risk.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PROF | Profound Medical Corp | -0.23 | 11 per month | 0.00 | -0.03 | 5.94 | -7.33 | 38.55 | |
| MXCT | MaxCyte | -0.06 | 8 per month | 0.00 | -0.23 | 6.10 | -6.90 | 16.23 | |
| CATX | Perspective Therapeutics | 0.20 | 8 per month | 4.96 | 0.15 | 11.81 | -8.83 | 77.44 | |
| AVR | Anteris Technologies Global | 0.12 | 7 per month | 3.48 | 0.11 | 9.42 | -5.99 | 25.09 | |
| PRE | Prenetics Global | -1.10 | 6 per month | 4.16 | 0.13 | 13.33 | -7.28 | 27.11 | |
| LNSR | LENSAR Inc | -0.13 | 7 per month | 0.00 | -0.05 | 2.58 | -3.27 | 9.35 | |
| NNOX | Nano X Imaging | -0.19 | 6 per month | 0.00 | -0.13 | 6.31 | -6.23 | 15.50 | |
| OWLT | Owlet Inc | 0.39 | 5 per month | 0.00 | -0.17 | 6.12 | -11.88 | 49.11 | |
| STIM | Neuronetics | -0.17 | 9 per month | 5.82 | 0.04 | 10.95 | -9.09 | 35.51 | |
| ARMP | Armata Pharmaceuticals | -0.64 | 4 per month | 4.68 | 0.18 | 14.07 | -7.66 | 34.69 |
Other Forecasting Options for TriSalus Life
For investors considering TriSalus, TriSalus Life's price movement is the most direct driver of investment returns. Noise in TriSalus Stock price charts can make identifying meaningful trends difficult without dedicated analytical tools.TriSalus Life Related Equities
The following equities are related to TriSalus Life within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing TriSalus Life against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
TriSalus Life Market Strength Events
Market strength indicators for TriSalus Life provide investors with a view of how the stock performs across different market environments. By analyzing these indicators, traders can determine the best moments to enter or exit positions in TriSalus Life Sciences.
| Accumulation Distribution | 0.0701 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 4.13 | |||
| Day Typical Price | 4.18 | |||
| Market Facilitation Index | 0.3 | |||
| Price Action Indicator | 0.15 | |||
| Relative Strength Index | 37.42 |
TriSalus Life Risk Indicators
A structured analysis of TriSalus Life's risk indicators is one of the most reliable ways to improve the accuracy of price forecasts. Understanding the risk embedded in TriSalus Life's allows investors to decide whether to accept, reduce, or hedge their exposure.
| Mean Deviation | 3.07 | |||
| Standard Deviation | 4.45 | |||
| Variance | 19.8 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for TriSalus Life
Story coverage around TriSalus Life Sciences often expands when market conditions, narrative momentum, or risk-adjusted performance make the security more visible to investors. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
TriSalus Life Short Properties
Short-interest signals around TriSalus Life Sciences can help investors judge whether skeptical positioning is starting to pressure price predictability and market tone. This is most valuable when investors want to know whether bearish pressure is starting to shape the market's reaction function.
| Common Stock Shares Outstanding | 37.9 M | |
| Cash And Short Term Investments | 20.4 M |
More Resources for TriSalus Stock Analysis
A structured review of TriSalus Life Sciences often starts with core financial statements and trend context. Financial ratios provide a structured lens for assessing TriSalus Life's profitability and growth trends. Below are reports that help frame TriSalus Life Sciences Stock in context:Historical Fundamental Analysis of TriSalus Life provides a cross-check on projections for TriSalus Life. The view provides historical context for the projection set. TriSalus Life currently shows ROE of -4.96%, market cap of 244.03 Million. TriSalus Life data on this page supports broader research - the resources below add portfolio-level context. A thorough TriSalus Life review pairs this page with the quantitative and comparative resources listed below. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Earnings Share -2.12 | Revenue Per Share | Quarterly Revenue Growth 0.598 | Return On Assets | Return On Equity |
The market value of TriSalus Life Sciences is measured differently than book value, which reflects TriSalus accounting equity. TriSalus Life's market capitalization is 244.03 M. At P/B 30.29, TriSalus Life trades at a significant premium to book value. Enterprise value stands at 255.47 M. Value and price for TriSalus Life are related but not identical, and they can diverge across cycles. Trading price represents the transaction level agreed by market participants.
Note that TriSalus Life's intrinsic value and market price are different measures derived from different inputs. For TriSalus Life, key inputs include a P/B ratio of 30.29, a profit margin of -86.88%, ROE of -4.96%, and revenue of 45.15 M. By contrast, TriSalus Life market price reflects the level where buyers and sellers transact.